LYFCX:NASDAQ
AlphaCentric Life Sciences and Healthcare Fund Class C – LYFCX Fund Overview
| Last Price | Today's Change | 52-Week Range | Trading Volume |
|---|
| 12.52 | 0.08 (+0.64%) | 11.17 - 13.81 | 0.0 |
Market data as of 12:00AM 04/02/25. Quotes are delayed by at least 15 min.
Overview - LYFCX
The investment seeks long-term capital appreciation.
Under normal market conditions, the fund invests at least 80% of its net assets plus borrowings for investment purposes in the securities of companies in the life sciences and healthcare sectors, which the managers define to be the category of companies related to producing or supplying facilities, supplies, technology, pharmaceuticals, equipment, devices or services for the preservation and care of a person’s or animal’s health.
Growth of $10,000 (10 Years)
| Total Return | 9.70% |
|---|
| Yield (Trailing 12 Mo.) | 1.09% |
|---|
| Expense Ratio | 2.66% |
|---|
| Front Load | None |
|---|
| Deferred Load | None |
|---|
| Minimum Investment | $2,500 |
|---|
| Management Tenure | 0 Years |
|---|
| Fund Inception | 11/29/2019 |
|---|
Trailing Total Returns - LYFCX
as of 02/28/2025
| Timeframe | LYFCX | S&P 500 | Health |
|---|
| 1 Month | 0.00% | -1.30% | -1.82% |
|---|
| 3 Month | -1.60% | -0.97% | -3.28% |
|---|
| Year-to-Date | 5.61% | 1.44% | 3.82% |
|---|
| 1 Year | 5.43% | 18.41% | -0.19% |
|---|
| 3 Year | 4.01% | 12.55% | 1.56% |
|---|
| 5 Year | 10.59% | 16.85% | 6.26% |
|---|
| 10 Year | -- | 12.98% | 6.03% |
|---|
| Since Inception | 9.70% | 11.12% | -- |
|---|
Sector Allocation - LYFCX
as of 02/28/2025
| Basic Materials | | 0.00% |
|---|
| Consumer Cyclical | | 0.00% |
|---|
| Financial Services | | 0.00% |
|---|
| Real Estate | | 0.00% |
|---|
| Consumer Defensive | | 0.00% |
|---|
| Healthcare | | 100.00% |
|---|
| Utilities | | 0.00% |
|---|
| Communication Services | | 0.00% |
|---|
| Energy | | 0.00% |
|---|
| Industrials | | 0.00% |
|---|
| Technology | | 0.00% |
|---|
Asset Allocation - LYFCX
as of 02/28/2025
| By Percent | Short | 0% | Long | Net |
|---|
| Stock | -- | | | 82.01 | 82.01 |
|---|
| Bond | -- | | | 0.00 | 0.00 |
|---|
| Other | -- | | | 0.00 | 0.00 |
|---|
| Foreign Stock | -- | | | 14.43 | 14.43 |
|---|
| Foreign Bond | -- | | | 0.00 | 0.00 |
|---|
| Total | -- | | | 96.44 | 96.44 |
|---|
| Cash | -- | | | 3.56 | 3.56 |
|---|
| Total Net Assets | $47.80M |
|---|
| Total Stock Holdings | 59 |
|---|
| Total Bond Holdings | 0 |
|---|
Top Ten Holdings - LYFCX
as of 02/28/2025
Valuation & Growth - LYFCX
as of 02/28/2025
| Valuation | LYFCX | Category Range |
|---|
| Price/Earnings | 30.53 | |
|---|
| Price/Book | 4.38 | |
|---|
| Price/Sales | 2.73 | |
|---|
| Price/Cash Flow | 19.65 | |
|---|
| Dividend Yield | 1.58 | |
|---|
| LT Earnings | 10.08 | |
|---|
| Historical Earnings | 5.74 | |
|---|
| Sales Growth | 8.81 | |
|---|
| Cash-Flow Growth | -3.98 | |
|---|
| Book-Value Growth | 9.63 | |
|---|
